Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

A somatostatin receptor-targeting peptide labeled with a Re(I) tricarbonyl core via a clickable tridentate bifunctional chelator

Lauren Radford, Fabio Gallazzi, Silvia Jurisson, Dionysia Papagiannopoulou and Heather Hennkens
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1079;
Lauren Radford
2Department of Chemistry University of Missouri Columbia MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabio Gallazzi
4Structural Biology Core University of Missouri Columbia MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Jurisson
2Department of Chemistry University of Missouri Columbia MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dionysia Papagiannopoulou
1School of Pharmacy Aristotle University of Thessaloniki Thessaloniki Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather Hennkens
3Research Reactor Center University of Missouri Columbia MO United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1079

Objectives We previously reported on the formation of Re- and 99mTc-tricarbonyl complexes using a tridentate chelator that coordinates the fac-[Re/99mTcI(CO)3]+ cores via imidazole N, thioether S, and carboxylate O donor atoms to yield stable neutral complexes. [1] Here, we report the synthetic modification of this ligand to generate a novel bifunctional chelator designed for both facile peptide conjugation and tridentate [NSO] coordination of Re/ 99mTc tricarbonyl cores. The synthesis, characterization and in vitro receptor affinity evaluation of a new Re(I)-labeled somatostatin receptor (SSTR)-targeting antagonist peptide are also presented.

Methods The novel tridentate chelating ligand, 2-(but-3-yn-1-ylthio)-3-(1H-imidazol-4-yl)propanoic acid (L), was synthesized by reacting 2-chloro-3-(1H-imidazol-4-yl)propanoic acid with S-(but-3-yn-1-yl) ethanethioate in a NaOH solution. The peptide sst2-ANT [2,3] [4-NO2-Phe-c(DCys-Tyr-DTrp-Lys-Thr- Cys)-DTyr-NH2] was first functionalized with an N-terminal azide via reaction with N3CH2COOH and then conjugated to the alkyne of L via a Cu(I)-assisted click reaction. The resulting L-sst2-ANT bioconjugate was reacted with the [Re(CO)3(H2O)3]+ intermediate [4] to yield Re(CO)3(L-sst2-ANT). The IC50 value of Re(CO)3(L-sst2-ANT) was determined via a challenge experiment in SSTR-expressing AR42J cells with 125I-Tyr11-somatostatin-14 as the competing radioligand.

Results The bifunctional chelating ligand L was synthesized in relatively low yield (29 %) and characterized by NMR and LCMS (m/z = 225.0 for [M+H]+, calc. 225.1). Click conjugation of L and resin-attached N3-sst2-ANT proceeded cleanly to yield L-sst2-ANT (m/z = 1462.5 for [M+H]+, calc. 1462.5). The synthesis of Re(CO)3(L-sst2-ANT) yielded two isomeric products in a 0.8:1 ratio with an 84% yield on average (by HPLC). HRMS analysis of the HPLC-purified Re products confirmed the expected m/z of 1732.6 (calc. 1732.4) for [M+H]+ and 866.8 (calc. 866.7) for [M+2H]2+, as well as the predicted isotopic pattern for Re. An IC50 value of 28 nM ± 13 nM was obtained for Re(CO)3(L-sst2-ANT), showing that acceptable SSTR affinity was retained after the addition of the metal complex.

Conclusions A novel bifunctional chelator for the fac-[Re/99mTcI(CO)3]+ cores was synthesized and successfully conjugated to sst2-ANT via an azide-alkyne cycloaddition reaction. Re(CO)3(L-sst2-ANT) was prepared in high yield and demonstrated nanomolar in vitro SSTR affinity, warranting further study of this new potential neuroendocrine cancer targeting agent. Ongoing tracer level experiments with 99mTc are promising.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A somatostatin receptor-targeting peptide labeled with a Re(I) tricarbonyl core via a clickable tridentate bifunctional chelator
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A somatostatin receptor-targeting peptide labeled with a Re(I) tricarbonyl core via a clickable tridentate bifunctional chelator
Lauren Radford, Fabio Gallazzi, Silvia Jurisson, Dionysia Papagiannopoulou, Heather Hennkens
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1079;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A somatostatin receptor-targeting peptide labeled with a Re(I) tricarbonyl core via a clickable tridentate bifunctional chelator
Lauren Radford, Fabio Gallazzi, Silvia Jurisson, Dionysia Papagiannopoulou, Heather Hennkens
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1079;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

SPECIAL MTA: Novel Radiochemistry & Chelation Posters

  • New 68ga hbed-bisphosponates and their derivatives as bone imaging agents
  • Radiosynthesis and initial in vitro evaluations of [18F]KBM-1 as a potential RAR-α imaging agent
  • In vitro binding affinities and initial in vivo evaluation of Ga-68-DATA-TOC
Show more SPECIAL MTA: Novel Radiochemistry & Chelation Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire